Pharmaceutical Technology

FEBRUARY 27, 2023

Antares Pharma overview Antares Pharma is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers.

Drug Delivery 100

Drug Delivery Drug Delivery Systems Production Drugs 100

XTalks

MAY 30, 2023

The patch itself is made of biodegradable nanocellulose and contains no plastic additives. The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. Behfar, senior scientist at VTT, in the news release.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

STAT News

NOVEMBER 3, 2022

The companies allege Moderna’s vaccine uses their technology for a drug-delivery system without permission. Citing Lilly announced earlier this year that the creation of its proposed manufacturing campus would create 300 permanent jobs once operational as well as 500 jobs during the construction phase.

Vaccination 97

Vaccination Vaccine Drug Delivery Systems Sales 97

Pharmaceutical Technology

APRIL 16, 2023

But with the advent of injection site absorption enhancers, drug delivery device innovations, as well as the recent primary container options, the practical subcutaneous self-administration of large-volume parenterals is becoming possible. For them, intravenous infusion in a hospital setting is the only option. autoinjector.

Protein 130

Protein Containment Drug Delivery Drugs 130

XTalks

MAY 18, 2023

The wireless charger — the transmitter — contains a metallic coil that converts electrical energy into a magnetic field, which is then collected and reverted into electricity by the receiver inside the implanted device. Our wireless charging for titanium cans changes all of that.” billion in 2022.

Development 96

Development Packaging Packaging Manufacturing 96

The Pharma Data

JANUARY 27, 2021

Construction of commercial drug manufacturing facility in Germany. Development of oral biosensor and contract development & manufacturing. Psychedelic transdermal and sublingual drug formulation development. Four clinical studies in neurological indications in 2021.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

XTalks

JULY 28, 2020

Excipients can take many forms, such as bulking agents, binders, coatings and colourants, and they are chosen based on their ability to aid in drug delivery, administration and even in pill identification and prevention of counterfeiting. But just how inert are these excipients?

Protein 103

Protein Drugs In-Vitro Scientist 103

The Pharma Data

DECEMBER 20, 2020

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Drug Delivery 52

Drug Delivery Containment Production Development 52

Druggist

OCTOBER 21, 2020

Curanail Once Weekly 5% Fungal Nail Treatment Curanail Once Weekly Fungal Nail treatment contains 5% of amorolfine hydrochloride as an active ingredient. delivery Excilor – review of clinical effectiveness Sleven et al. Products which were found inactive in the experiment did not contain any organic acids.

Production 98

Production Containment In-Vitro Sales 98

The Pharma Data

NOVEMBER 2, 2020

“Psychedelic agents are a promising new class of therapeutic drug. We see a natural opportunity to apply XPhyto’s drug formulation expertise and Vektor’s proven drug delivery platforms to these emerging APIs,” said Hugh Rogers, CEO and Director of XPhyto. About XPhyto Therapeutics Corp.

Production 52

Production Development Drug Delivery Drugs 52

Roots Analysis

JUNE 6, 2024

The continuous evolution of autoinjectors reflects a significant shift towards empowering patients to take control of their treatment, ensuring timely and accurate medication delivery for better health management. In January 2024, Rx Bandz signed a manufacturing agreement with Weiss-Aug for their MiniJect autoinjector.

Medicine 40

Medicine Drug Delivery Manufacturing Marketing 40

Roots Analysis

JANUARY 17, 2024

They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. However, this needle system does not contain a proper locking system, therefore, increased the chances of leakage.

Drug Delivery 40

Drug Delivery Contamination Drugs Production 40

The Pharma Data

JANUARY 3, 2021

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Except as required by law, TLC expressly disclaims any responsibility to update any forward-looking statement contained herein, whether as a result of new information, future events or otherwise.

Clinical Trials 52

Clinical Trials Clinical Trials Containment Development 52

XTalks

AUGUST 30, 2022

Big pharmaceutical companies require a system of hierarchy to accurately adhere to the legal and regulatory requirements for drug delivery, drug approval, supply chain and manufacturing processes. Although these leadership styles are of very different natures, they also contain some commonalities.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105

The Pharma Data

DECEMBER 14, 2020

(“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLC ’s (“Transcend”) manufacturing patent “Process of synthesizing 2-Bromo-LSD.”.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

The Pharma Data

OCTOBER 20, 2020

” Mr. Bliss joins TLC following interim roles in cellular therapy, drug delivery and combination therapy where he led efforts to confirm research outcomes and partner the various technologies. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Licensing 40

Licensing Licensing Drug Delivery Business Development 40

The Pharma Data

JANUARY 25, 2021

Certain assets, including gold nanoparticle manufacturing equipment were transferred to Cardiff and others were sold. ” This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR). We are well positioned for a productive 2021.”

Containment 52

Containment Drug Delivery Licensing Licensing 52

The Pharma Data

JANUARY 3, 2021

1 Good Manufacturing Practice. Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Edward Hæggström, CEO. edward.haeggstrom@nanoform.com. 358 29 370 0150.

Containment 40

Containment Bioavailability Clinical Trials Clinical Trials 40

The Pharma Data

NOVEMBER 4, 2020

He has 25 years’ experience including executive roles with major international European and Asian-based pharmaceutical companies and has more recently led a number of successful ventures in the pharmaceutical manufacturing, nutraceutical and other industry sectors. Thoresen is an important addition to XPhyto’s board of directors.

Drug Delivery 40

Drug Delivery Production Manufacturing Development 40

The Pharma Data

JANUARY 17, 2021

The Company will continue to leverage its scientific expertise and operations in Europe and North America for product development and optimization while it plans to add significant commercial experience in the fields of manufacturing, distribution, marketing and sales. About XPhyto Therapeutics Corp. XPhyto Therapeutics Corp.

Production 40

Production Development Drug Delivery Drugs 40

The Pharma Data

DECEMBER 17, 2020

In addition, TLC is preparing for scale-up production of TLC590, as for complex lipid products, the manufacturing process and batch size used in pivotal clinical trials and New Drug Application submission must be the same as future commercial batches. Cautionary Note on Forward-Looking Statements. Source link.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Containment 40

The Pharma Data

NOVEMBER 9, 2020

On November 3, 2020, the Company announced a research agreement with a leading German university for the exclusive development of a proprietary biotechnology process for the industrial manufacture of psilocybin as a certified active pharmaceutical ingredient (“API”). About XPhyto Therapeutics Corp. XPhyto Therapeutics Corp.

Development 40

Development Drugs Drug Delivery Production 40

The Pharma Data

NOVEMBER 4, 2020

(TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

FDA Law Blog

MARCH 12, 2024

Koblitz — After years of silence from FDA on whether certain patents could be listed in the Orange Book, some manufacturers of drug and device combination products have had a rude awakening lately.

Drugs 45

Drugs Drug Delivery Systems Regulation Production 45

Roots Analysis

AUGUST 8, 2023

The hydrophobic portion contains two fatty acid chains with 10-24 carbon atoms, while the hydrophilic part primarily consists of phosphoric acid linked to a water-soluble molecule. Therapeutic Applications of Liposomes in Drug Delivery In comparison to existing formulations, liposomes offer greater therapeutic efficacy and safety.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs In-Vivo 52

Delveinsight

JANUARY 22, 2021

The drug provides an alternative to the current replacement of ADAMTS13 using large volumes of fresh frozen plasma that contain variable amounts of ADAMTS13 and typically require two hours or more for the preparation and infusion.

Marketing 65

Marketing Drugs Antibody Compliance 65

Roots Analysis

FEBRUARY 18, 2022

Myeloid cells represent a group of cells containing granulocytes, monocytes, macrophages, mast cells and dendritic cells, which play a key role in innate immunity. These cells are found in abundance in the tumor microenvironment and inflamed areas. Myeloid Cells Targeting Therapeutics Market. Our Social Media Platform. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 27, 2020

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Except as required by law, TLC expressly disclaims any responsibility to update any forward-looking statement contained herein, whether as a result of new information, future events or otherwise.

Trials 40

Trials Clinical Trials Clinical Trials Containment 40

Roots Analysis

FEBRUARY 13, 2023

As a result, there is an evident increase in the demand for mRNA manufacturing capacity. The key applications of mRNAs are below: Contract Manufacturing in mRNA Synthesis AND Manufacturing Service Domain The synthesis and manufacturing process of mRNA-based therapeutics / vaccines is complex and associated with several challenges.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

The Pharma Data

JANUARY 15, 2021

and Genmab A/S entered into a worldwide agreement, which granted Janssen an exclusive license to develop, manufacture and commercialize daratumumab. Darzalex Faspro® is co-formulated with recombinant human hyaluronidase PH20 (rHuPH20), Halozyme’s ENHANZE® drug delivery technology. Janssen Biotech, Inc.

FDA Approval 52

FDA Approval Production Research Development 52

XTalks

JANUARY 23, 2025

PBMs serve as intermediaries between insurers, pharmacies and drug manufacturers, negotiating discounts and managing drug formularies. While PBMs were originally intended to lower costs and streamline drug delivery, critics argue that their practices often lead to inflated prices and restricted access for consumers.

Drugs 59

Drugs Generic Drugs Pharmacy Insulin 59